EGFR and neoplasm: Conversely, when the RTK/RAS pathway drives gliomagenesis (by NF1 inactivation and EGFR amplification in C3 and C4 models, respectively), the inferred tumor progression relies on the acquisition of PTEN alterations, and subsequent up-regulation of the PI3K pathway.